Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Abhay Joshi currently holds 120,708 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Abhay Joshi has been a net neutral trader of RVNC stock. They have purchased $0 and sold $0 worth of shares.
Abhay Joshi's most recent insider trade was on Mar 15, 2022, when they sold 2,607 shares at $15.79 per share.
Abhay Joshi serves as Executive at Revance Therapeutics, Inc. (RVNC). They have executed 31 insider transactions totaling $0 over their tenure at the company.
Abhay Joshi holds the position of Executive at Revance Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Abhay Joshi has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Abhay Joshi was on Sep 30, 2020, when they sold $185.6K worth of RVNC shares. This transaction involved 7,382 shares at $25.14 per share.
Abhay Joshi currently owns 120,708 shares of Revance Therapeutics, Inc. (RVNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Abhay Joshi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Abhay Joshi has 31 Form 4 filings on record as an insider at Revance Therapeutics, Inc..
Set alerts for Abhay Joshi and 40,000+ other insiders.